TELO ▲ +5.3% - Telomir Pharmaceuticals, Inc. $TELO - Telomir Announces Peer-Reviewed Publication Showing Telomir-Zn Restores Visual Function and Retinal Structure in a Model of Age-Related Macular Degeneration (AMD) Telomir Pharmaceuticals rose 5.3% after announcing the publication of peer-reviewed research demonstrating that its experimental drug Telomir-Zn restored visual function and retinal structure in an age-related macular degeneration model. The positive preclinical data may have encouraged investors about the therapeutic potential of the company's lead candidate for a significant cause of vision loss. 17-SEP-2026 08:30 AM ET